Trial intelligence / Profile preview

Metformin in heart failure patients with glucose intolerance

2009-010292-24Phase 2Terminated

Sponsor
IRCCS Ospedale San Raffaele
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of metformin in chronic heart failure (CHF) and dysglycemia, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Change in cardiac function. Started Mar 2009; status: terminated.

02

Drugs

metformin
03

Conditions

chronic heart failure (CHF)dysglycemia

Beyond the preview

Go deeper on 2009-010292-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010292-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call